Search for dissertations about: "DLBCL"

Showing result 1 - 5 of 34 swedish dissertations containing the word DLBCL.

  1. 1. Prognostic Markers in Diffuse Large B-cell Lymphoma How Bad can it be

    University dissertation from Uppsala : Acta Universitatis Upsaliensis

    Author : Gustaf Hedström; Uppsala universitet.; [2014]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; DLBCL; Survival; Mast cell; Microenvironment; MicroRNA; MDM2; Polymorphism; Age; Epidemiology; Oncology; Onkologi;

    Abstract : Diffuse large B-cell lymphoma (DLBCL), which is the most common type of lymphoma, is characterised by its aggressiveness and poor outcome without adequate treatment and also for its biological and clinical heterogeneity. It is therefore highly desirable to gain a more profound understanding of the underlying biology of the disease, as well as predictive factors for the guidance of treatment. READ MORE

  2. 2. Potential New Drugs in Lymphoma

    University dissertation from Uppsala : Acta Universitatis Upsaliensis

    Author : Maryam Delforoush; Uppsala universitet.; [2016]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; lymphoma; diffuse large B-cell lymphoma; DLBCL; picropodophyllin; PPP; J1; melflufen; prodrug; cancer therapeutics; alkylating agents; b-AP15; proteasome inhibitors; DUB inhibition; UCHL5; USP14;

    Abstract : Lymphomas are malignant tumours arising from cells in the lymphatic system. They are classified as B-cell lymphomas, T-cell lymphomas and Hodgkin lymphoma (HL). Of the B-cell lymphomas, one of the most common is diffuse large B-cell lymphoma (DLBCL). READ MORE

  3. 3. Diffuse large B-cell lymphoma - proteomic and metabolomic studies on prognosis and treatment failure

    University dissertation from Uppsala : Acta Universitatis Upsaliensis

    Author : Martin Stenson; Göteborgs universitet.; Gothenburg University.; [2018]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; DLBCL; prognostics; proteomics; metabolomics;

    Abstract : Abstract Background and aim: Every year almost 600 patients in Sweden are diagnosed with diffuse large B-cell lymphoma (DLBCL), the most common lymphoma, and with immunochemotherapy, approximately 60 % are cured. Yet, for patients with primary refractory disease or early relapse, the prognosis is very poor. READ MORE

  4. 4. Diffuse large B-cell lymphoma – studies on immunohistochemical and clinical prognostic factors

    University dissertation from Uppsala : Acta Universitatis Upsaliensis

    Author : Sverker Hasselblom; Göteborgs universitet.; Gothenburg University.; [2010]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; DLBCL; prognosis; sex; population-based; apoptosis; Ki-67; CTLs; TIA-1; FOXP3; bcl-2; GCB; p-AKT;

    Abstract : DLBCL, the most common lymphoma entity, is a potentially curable but heterogeneous disease. Most studies concerning therapy and prognostic factors have been performed on selected patient materials. It is important to identify immunohistochemical biomarkers which could add prognostic information to clinical factors. READ MORE

  5. 5. Prognostic Markers and Mechanisms of Chemotherapy Resistance in Diffuse Large B-cell Lymphoma

    University dissertation from Department of Clinical Sciences, Lund University

    Author : Karin Fjordén; Lunds universitet.; Lund University.; Lunds universitet.; Lund University.; [2015]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES;

    Abstract : Popular Abstract in Swedish Lymfom är en grupp tumörsjukdomar som uppkommer från de vita blodkropparna i vårt immunförsvar. Diffust storcelligt B-cellslymfom (DLBCL) är en av de mest aggressiva varianterna av lymfom och uppkommer från den typen av vita blodkroppar som kallas B-celler. Varje år drabbas ca 500 personer i Sverige av DLBCL. READ MORE